ClinicalTrials.gov
ClinicalTrials.gov Menu

An Autism Study Using Nambudripad's Food Allergy Elimination Treatments

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00247156
Recruitment Status : Completed
First Posted : November 1, 2005
Last Update Posted : June 26, 2008
Sponsor:
Information provided by:
Nambudripad's Allergy Research Foundation

Brief Summary:
1. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.

Condition or disease Intervention/treatment Phase
Autism Food Allergies Procedure: Acupressure treatments and NAET treatments Phase 1 Phase 2

  Show Detailed Description

Study Type : Interventional  (Clinical Trial)
Enrollment : 60 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: An Investigation Into the Effectiveness of NAET on Autism Spectrum Disorders
Study Start Date : November 2004
Study Completion Date : November 2005

Resource links provided by the National Library of Medicine

U.S. FDA Resources




Primary Outcome Measures :
  1. Improvement in speech and communication

Secondary Outcome Measures :
  1. Elimination or reduction of commonly seen autistic traits


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   3 Years to 10 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Volunteers will be selected based on the well-defined inclusion criteria such as all control and sample children showed typical autistic symptoms before NAET® treatment: made no eye contact, unable to talk and communicate. All subjects (both control and sample) should be within the age limit of 3 to10 years and should have established and demonstrated autism spectrum disorder by a conventional physician. -

Exclusion Criteria:

Any child that has a history of various complications of illness other than autism spectrum disorder would be disqualified. Previously treated with NAET treatments for this condition will be disqualified to enroll in the study. Any patient who has any of the following incidents will also be disqualified.

  1. Previous surgeries, congenital deformities of heart, lung, liver, brain, kidney, etc.
  2. Any type of cancer
  3. Aids
  4. Any physically debilitating disorders and diagnosed mental retardation, Down's syndrome, etc.
  5. Children with the history of severe allergies or anaphylactic reactions will be rejected.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00247156


Locations
United States, California
PNIB Research Center
Buena Park, California, United States, 90621
Sponsors and Collaborators
Nambudripad's Allergy Research Foundation
Investigators
Principal Investigator: Devi S. Nambudripad, LAc, PhD The journal of NAET Energetics and Complementary Medicine

ClinicalTrials.gov Identifier: NCT00247156     History of Changes
Other Study ID Numbers: narfoundationautismstudy
narffoundation 101
First Posted: November 1, 2005    Key Record Dates
Last Update Posted: June 26, 2008
Last Verified: April 2006

Keywords provided by Nambudripad's Allergy Research Foundation:
Autism
eye contact
Noncommunicable

Additional relevant MeSH terms:
Autistic Disorder
Hypersensitivity
Food Hypersensitivity
Child Development Disorders, Pervasive
Neurodevelopmental Disorders
Mental Disorders
Immune System Diseases
Hypersensitivity, Immediate